Mishal Khan: Long-Term Mortality Trends and Demographic Disparities in Patients With PE and AF
Mishal Khan, President VFAHT-FMC at Infection Prevention and Control Foundation and Vice President FMC LC at IFMSA-Pakistan, shared on LinkedIn about a recent article she and her colleagues co-authored, published in Journal of Arrhythmia, adding:
“Excited to share our latest publication in the Journal of Arrhythmia:
‘Trends and Disparities in Mortality due to Pulmonary Embolism Among Adults With Atrial Fibrillation From 1999 to 2020: Insights From the CDC WONDER Database’
Using over two decades of national mortality data, our study is among the first to characterize long-term mortality trends and demographic disparities in patients with pulmonary embolism (PE) and coexisting atrial fibrillation (AF).
We found that PE-related mortality in patients with AF has risen significantly since 2009, with disproportionately higher mortality among men, rural populations, and certain geographic regions.
These findings highlight important inequities in cardiovascular outcomes and identify populations that may benefit from targeted prevention and healthcare interventions.
Beyond describing trends, our work provides a foundation for future research exploring the drivers of these disparities, including anticoagulation access and adherence, healthcare infrastructure, and socioeconomic factors.
It also supports the need for policies that strengthen AF screening, improve access to specialized cardiovascular care in underserved regions, and expand telemedicine-based anticoagulation management.
Grateful to all my co-authors for their incredible collaboration throughout this project.”
Title: Trends and Disparities in Mortality due to Pulmonary Embolism Among Adults With Atrial Fibrillation From 1999 to 2020: Insights From the CDC WONDER Database
Authors: Eeman Ahmad, Mishal Khan, Muhammad Ans, Hoor Ul Ain, Ahmad Qaisar, Shahzaib Ahmed, Olivier Uwishema, Ibrahim Nagmeldin Hassan, Muhammad Saad, Abbas Hayat Mallick, M Chadi Alraies
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 29, 2026, 13:12Wolfgang Miesbach: Teclistamab Targets the Source of Pathogenic Autoantibodies
-
Sep 29, 2026, 12:37Dan Milikovsky: Uncovering Cerebrovascular Injury in Sickle Cell Disease
-
Sep 29, 2026, 12:02Hajra Malik: Bridging Language Gaps in Hematology With AI
-
Sep 29, 2026, 11:57Joan Montaner: Can Blood Test Identify Intracerebral Hemorrhage Within Minutes?
-
Sep 29, 2026, 11:43From Years Without Answers to Life With Hemophilia Care – WFH
-
Sep 29, 2026, 11:32Sara Al Dallal: Transforming Hemophilia Care Across the Gulf
-
Sep 29, 2026, 11:21Richard Davis: Rapid Rescue in Massive Pulmonary Embolism
-
Sep 29, 2026, 11:14Nissan Brown: Every Step Counts for the Hemophilia Community
-
Sep 29, 2026, 11:03Zain Khalpey: SINGLE AF Adds New Evidence to the Anticoagulation Debate